Literature DB >> 17356906

Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.

Eigil Husted Nielsen1, Jörgen Lindholm, Peter Laurberg, Per Bjerre, Jens Sandahl Christiansen, Claus Hagen, Svend Juul, Jesper Jørgensen, Anders Kruse, Kirstine Stochholm.   

Abstract

The incidence of clinically significant, nonfunctioning pituitary adenoma, requiring surgical treatment, has not been established. According to previous studies, both surgery type and subsequent radiotherapy may have an impact on quality of life (QOL), and some studies have shown increased cardiovascular mortality in patients with pituitary disease. We studied all patients with functionless, suprasellar pituitary adenoma who were operated on during the period 1985-1996 (N = 192; transsphenoidal surgery = 160, craniotomy = 32). QOL was evaluated from Short Form 36 and Major Depression Inventory questionnaires. Causes of death were obtained from the Danish Register of Causes of Death. Incidence was 5.6/mill/year. Postoperatively, 27% of the patients had normal pituitary function and 27% were panhypopituitary. Fifty three patients had died. Death from cardiovascular, cerebrovascular and malignant diseases was not increased. Overall, QOL was not different from QOL of an age- and sex matched background population. QOL was, however, impaired in patients who had undergone craniotomy as compared to patients undergoing transsphenoidal surgery. QOL was not reduced in hypopituitary patients or in patients receiving radiotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17356906     DOI: 10.1007/s11102-007-0018-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  24 in total

1.  Cerebrovascular mortality in patients with pituitary adenoma.

Authors:  M Brada; S Ashley; D Ford; D Traish; L Burchell; B Rajan
Journal:  Clin Endocrinol (Oxf)       Date:  2002-12       Impact factor: 3.478

2.  Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

Authors:  B Nilsson; E Gustavasson-Kadaka; B A Bengtsson; B Jonsson
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

3.  The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease.

Authors:  K A Peace; S M Orme; J P Sebastian; A R Thompson; S Barnes; A Ellis; P E Belchetz
Journal:  Clin Endocrinol (Oxf)       Date:  1997-04       Impact factor: 3.478

4.  An account of the quality of life of patients after treatment for non-functioning pituitary tumours.

Authors:  R C Page; M S Hammersley; C W Burke; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1997-04       Impact factor: 3.478

5.  Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma.

Authors:  O M Dekkers; A A van der Klaauw; A M Pereira; N R Biermasz; P J Honkoop; F Roelfsema; J W A Smit; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

6.  Life expectancy following surgery for pituitary tumours.

Authors:  A S Bates; B Bullivant; M C Sheppard; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

7.  Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.

Authors:  J Svensson; B-A Bengtsson; T Rosén; A Odén; G Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

8.  Quality of life in patients with a pituitary adenoma.

Authors:  Michelle D Johnson; C J Woodburn; Mary Lee Vance
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

9.  Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.

Authors:  Joselina Luzia Menezes Oliveira; Celi Marques-Santos; José Augusto Barreto-Filho; Roberto Ximenes Filho; Allan Valadão de Oliveira Britto; Anita Hermínia Oliveira Souza; Clarisse Miranda Prado; Carla Raquel Pereira Oliveira; Rossana Maria C Pereira; Tábita de Almeida Ribeiro Vicente; Catarine Teles Farias; Manuel Hermínio Aguiar-Oliveira; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

10.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

View more
  19 in total

1.  Health-related quality of life and fatigue in patients with adrenal incidentaloma.

Authors:  Darko Kastelan; Fedja Dzubur; Tina Dusek; Tamara Poljicanin; Zeljka Crncevic-Orlic; Ivana Kraljevic; Mirsala Solak; Tanja Bencevic; Izet Aganovic; Nikola Knezevic; Zeljko Kastelan; Mirko Korsic
Journal:  Endocrine       Date:  2011-03-26       Impact factor: 3.633

2.  Hypoadrenalism presenting as a range of mental disorders.

Authors:  Aleksandar Pavlovic; Velusamy Sivakumar
Journal:  BMJ Case Rep       Date:  2011-03-03

Review 3.  Mortality in adults with hypopituitarism: a systematic review and meta-analysis.

Authors:  Sina Jasim; Fares Alahdab; Ahmed T Ahmed; Shrikant Tamhane; Larry J Prokop; Todd B Nippoldt; M Hassan Murad
Journal:  Endocrine       Date:  2016-11-05       Impact factor: 3.633

4.  Long-term outcomes of endoscopic endonasal approach for skull base surgery: a prospective study.

Authors:  Elena Rioja; Manuel Bernal-Sprekelsen; Karla Enriquez; Joaquim Enseñat; Ricard Valero; Matteo de Notaris; Joaquim Mullol; Isam Alobid
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

5.  Anatomic Variations in Pituitary Endocrinopathies: Implications for the Surgical Corridor.

Authors:  Edward C Kuan; Frederick Yoo; Won Kim; Karam W Badran; Thomas E Heineman; Ali R Sepahdari; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2016-08-10

Review 6.  Olfactory outcomes after endonasal skull base surgery: a systematic review.

Authors:  Junhao Zhu; Kaiyang Feng; Chao Tang; Jin Yang; Xiangming Cai; Chunyu Zhong; Chiyuan Ma
Journal:  Neurosurg Rev       Date:  2020-09-10       Impact factor: 3.042

7.  Imaging of Resected Nonfunctioning Pituitary Adenomas: The Cost of Surveillance.

Authors:  Heather M Kistka; Rebecca A Kasl; Arash Nayeri; Andrea L Utz; Kyle D Weaver; Lola B Chambless
Journal:  J Neurol Surg B Skull Base       Date:  2015-05-08

Review 8.  Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.

Authors:  Maria Gueorguiev; Ashley B Grossman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 9.  Improving Quality of Life in Patients with Pituitary Tumours.

Authors:  Iris Crespo; Alicia Santos; Eugenia Resmini; Elena Valassi; Maria Antonia Martínez-Momblán; Susan M Webb
Journal:  Eur Endocrinol       Date:  2013-03-15

10.  Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature.

Authors:  C Di Somma; E Scarano; G de Alteriis; L Barrea; E Riccio; R Arianna; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2020-09-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.